Liabilities and Equity in USD of BioAge Labs, Inc. from Q4 2023 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: BioAge Labs, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2023 to Q3 2025.
BioAge Labs, Inc. Liabilities and Equity for the quarter ending September 30, 2025 was $305M, a 9.57% decline year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

BioAge Labs, Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$305M	-$32.3M	-9.57%	Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$322M			Jun 30, 2025	10-Q	2025-08-06
Q1 2025	$344M			Mar 31, 2025	10-Q	2025-05-06
Q4 2024	$358M	+$332M	+1282%	Dec 31, 2024	10-Q	2025-11-06
Q3 2024	$337M			Sep 30, 2024	10-Q	2024-11-07
Q4 2023	$25.9M			Dec 31, 2023	10-K	2025-03-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.